Nearly 25 years ago, a paper was published about addiction that transformed the field. The director of the US National Institute on Drug Abuse at the time called addiction a “brain disease,” and he wrote a paper articulating this position and the agenda that it implied. It led to a focus on researching the brain to understand the mechanisms behind addiction, which could lead to novel treatments. And it meant that the country began to treat addiction as a disease, thus treating it within the medical system and removing the victim-blaming stigma. Over the years, there has been a pushback against the view of addiction as a brain disease, even within the scientific community. In part, this occurred because research in neuroscience didn’t lead to effective treatments as quickly as the field hoped or promised. And in part, says Markus Heilig, it’s because other researchers felt that funding into the neuroscience of addition meant that other relevant mechanisms, such as social and psychological factors, were perhaps being somewhat neglected. Dr. Heilig and his colleagues recently published a review addressing these and other concerns. Listen in to learn more!
See acast.com/privacy for privacy and opt-out information.
Ghrelin decreases sensitivity to negative feedback and increases prediction-error related caudate activity in humans, a randomized controlled trial
Spotlighting SHAPERS: Sex hormones associated with psychological and endocrine roles
Comparable roles for serotonin in rats and humans for computations underlying flexible decision-making
Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanyl
The why, when, where, how, and so what of so-called rapidly acting antidepressants
AI-based analysis of social media language predicts addiction treatment dropout at 90 days
Oxytocin effects on amygdala reactivity to angry faces in males and females with ASPD
To dismantle structural racism in science, scientists need to learn how it works
Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity
Sex-dependent risk factors for PTSD: a prospective structural MRI study
Sex differences in appetitive and reactive aggression
What’s wrong with my experiment?: The impact of hidden variables on neuropsychopharmacology research
A scientific approach to navigating the academic job market
Identification of THC impairment using functional brain imaging
Evolution of prefrontal cortex
Astrocyte-neuron signaling in the mesolimbic dopamine system: the hidden stars of dopamine signaling
Neurobiology of loneliness: a systematic review
Medial orbitofrontal cortex dopamine D1/D2 receptors differentially modulate distinct forms of probabilistic decision-making
Big data in psychiatry: multiomics, neuroimaging, computational modeling, and digital phenotyping
Create your
podcast in
minutes
It is Free